Additionally, immunoprecipitation assays revealed that DYRK1A can interact with TSC1 and SMAD2/3, indicating that the DYRK1A-TSC1-SMAD2/3 complex might play a vital role in HCC tumorigenesis (Fig. 5e). The gene discussed is DYRK1A; the disease is hepatocellular carcinoma.